Those determined to outshine the market strategically focus on the selection of individual stocks. Well-chosen stocks have the potential to substantially boost your wealth.
After finishing at $18.77 in the prior trading day, Teva- Pharmaceutical Industries Ltd. ADR (NYSE: TEVA) closed at $17.43, down -7.14%. In other words, the price has decreased by -$7.14 from its previous closing price. On the day, 18.21 million shares were traded. TEVA stock price reached its highest trading level at $19.3 during the session, while it also had its lowest trading level at $17.18.
Ratios:
Our goal is to gain a better understanding of TEVA by taking a closer look at its different ratios. It provided that stocks Price–to–Cash (P/C) ratio for the trailing twelve months (TTM) is standing at 8.75 whereas its Price-to-Free Cash Flow (P/FCF) for the term is 9.52. For the most recent quarter (mrq), Quick Ratio is recorded 0.59 and its Current Ratio is at 0.89. In the meantime, Its Debt-to-Equity ratio is 2.98 whereas as Long-Term Debt/Eq ratio is at 2.65.
On March 08, 2024, JP Morgan Upgraded its rating to Neutral which previously was Underweight but kept the price unchanged to $14.
Piper Sandler Upgraded its Neutral to Overweight on February 12, 2024, whereas the target price for the stock was revised from $12 to $19.
Insider Transactions:
The insider trade also gives investors a glimpse into the future direction of stock prices, which can be beneficial to investors. A recent insider transaction in this stock occurred on Aug 12 ’24 when Daniell Richard sold 98,943 shares for $17.30 per share. The transaction valued at 1,711,447 led to the insider holds 0 shares of the business.
Grant Angus sold 4,065 shares of TEVA for $70,243 on Aug 09 ’24. The EVP, Business Development now owns 8,848 shares after completing the transaction at $17.28 per share. On Aug 09 ’24, another insider, Hughes Eric A, who serves as the of the company, sold 45,060 shares for $17.38 each. As a result, the insider received 782,972 and left with 0 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, TEVA now has a Market Capitalization of 20100276224 and an Enterprise Value of 38132699136. For the stock, the TTM Price-to-Sale (P/S) ratio is 1.21 while its Price-to-Book (P/B) ratio in mrq is 3.11. Its current Enterprise Value per Revenue stands at 2.341 whereas that against EBITDA is 8.353.
Stock Price History:
Over the past 52 weeks, TEVA has reached a high of $19.08, while it has fallen to a 52-week low of $8.55. The 50-Day Moving Average of the stock is -3.15%, while the 200-Day Moving Average is calculated to be 9.78%.
Shares Statistics:
The stock has traded on average 6.48M shares per day over the past 3-months and 5901050 shares per day over the last 10 days, according to various share statistics. A total of 1.13B shares are outstanding, with a floating share count of 1.13B. Insiders hold about 0.01% of the company’s shares, while institutions hold 54.13% stake in the company. Shares short for TEVA as of 1728950400 were 19909280 with a Short Ratio of 3.07, compared to 1726185600 on 30341365. Therefore, it implies a Short% of Shares Outstanding of 19909280 and a Short% of Float of 1.77.
Dividends & Splits
The stock’s 5-year Average Dividend Yield is 2.95.
